-
2
-
-
33846457870
-
Cancer statistics, 2007
-
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007:57:43-66.
-
(2007)
CA Cancer J Clin
, vol.57
, pp. 43-66
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Murray, T.4
Xu, J.5
Thun, M.J.6
-
3
-
-
27244434474
-
Current treatment approaches for mantle-cell lymphoma
-
Witzig TE. Current treatment approaches for mantle-cell lymphoma. J Clin Oncol. 2005;23: 6409-6414.
-
(2005)
J Clin Oncol
, vol.23
, pp. 6409-6414
-
-
Witzig, T.E.1
-
5
-
-
0027293137
-
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts
-
Quelle DE, Ashmun RA, Shurtleff SA, et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 1993; 7:1559-1571.
-
(1993)
Genes Dev
, vol.7
, pp. 1559-1571
-
-
Quelle, D.E.1
Ashmun, R.A.2
Shurtleff, S.A.3
-
6
-
-
0028173667
-
Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system
-
Resnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol. 1994;14:1669-1679.
-
(1994)
Mol Cell Biol
, vol.14
, pp. 1669-1679
-
-
Resnitzky, D.1
Gossen, M.2
Bujard, H.3
Reed, S.I.4
-
7
-
-
33645118564
-
Cyclin D1: Polymorphism, aberrant splicing and cancer risk
-
Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene. 2006:25:1620-1628.
-
(2006)
Oncogene
, vol.25
, pp. 1620-1628
-
-
Knudsen, K.E.1
Diehl, J.A.2
Haiman, C.A.3
Knudsen, E.S.4
-
8
-
-
0032533225
-
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization
-
Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 1998;12:3499-3511.
-
(1998)
Genes Dev
, vol.12
, pp. 3499-3511
-
-
Diehl, J.A.1
Cheng, M.2
Roussel, M.F.3
Sherr, C.J.4
-
9
-
-
0242526150
-
An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene
-
Lu F, Gladden AB, Diehl JA. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res. 2003:63:7056-7061.
-
(2003)
Cancer Res
, vol.63
, pp. 7056-7061
-
-
Lu, F.1
Gladden, A.B.2
Diehl, J.A.3
-
10
-
-
34249723211
-
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
-
Wiestner A, Tehrani M, Chiorazzi M, et al. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood. 2007;109:4599-4606.
-
(2007)
Blood
, vol.109
, pp. 4599-4606
-
-
Wiestner, A.1
Tehrani, M.2
Chiorazzi, M.3
-
11
-
-
12144290519
-
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
-
Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004;101: 2999-3004.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 2999-3004
-
-
Calin, G.A.1
Sevignani, C.2
Dumitru, C.D.3
-
12
-
-
0037009364
-
MicroRNA maturation: Stepwise processing and subcellular localization
-
Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. Embo J. 2002;21:4663-4670.
-
(2002)
Embo J
, vol.21
, pp. 4663-4670
-
-
Lee, Y.1
Jeon, K.2
Lee, J.T.3
Kim, S.4
Kim, V.N.5
-
13
-
-
11844278458
-
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
-
Lewis BP. Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15-20.
-
(2005)
Cell
, vol.120
, pp. 15-20
-
-
Lewis, B.P.1
Burge, C.B.2
Bartel, D.P.3
-
14
-
-
0346094457
-
Prediction of mammalian microRNA targets
-
Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Bürge CB. Prediction of mammalian microRNA targets. Cell. 2003;115:787-798.
-
(2003)
Cell
, vol.115
, pp. 787-798
-
-
Lewis, B.P.1
Shih, I.H.2
Jones-Rhoades, M.W.3
Bartel, D.P.4
Bürge, C.B.5
-
15
-
-
34547854381
-
The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia
-
Calin GA, Pekarsky Y, Croce CM. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol. 2007:20:425-437.
-
(2007)
Best Pract Res Clin Haematol
, vol.20
, pp. 425-437
-
-
Calin, G.A.1
Pekarsky, Y.2
Croce, C.M.3
-
16
-
-
33846283385
-
The evolution of gene regulation by transcription factors and microRNAs
-
Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 2007:8:93-103.
-
(2007)
Nat Rev Genet
, vol.8
, pp. 93-103
-
-
Chen, K.1
Rajewsky, N.2
-
17
-
-
34250851115
-
A microRNA component of the p53 tumour suppressor network
-
He L, HeX, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447:1130-1134.
-
(2007)
Nature
, vol.447
, pp. 1130-1134
-
-
He, L.1
He, X.2
Lim, L.P.3
-
18
-
-
4143142117
-
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
-
Calin GA, Liu CG, Sevignani C, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A. 2004;101:11755-11760.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 11755-11760
-
-
Calin, G.A.1
Liu, C.G.2
Sevignani, C.3
-
19
-
-
84888575330
-
-
Calin GA, Ferraoin M, CimminoA, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
-
Calin GA, Ferraoin M, CimminoA, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.
-
-
-
-
20
-
-
27244434788
-
-
N Engl J Med. 2005;353:1793-1801.
-
(2005)
N Engl J Med
, vol.353
, pp. 1793-1801
-
-
-
21
-
-
25444520537
-
miR-15 and miR-16 induce apoptosis by targeting BCL2
-
Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102:13944-13949.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 13944-13949
-
-
Cimmino, A.1
Calin, G.A.2
Fabbri, M.3
-
22
-
-
84868905801
-
-
Whitehead Institute for Biomedical Research, Accessed April 1, 2008
-
Whitehead Institute for Biomedical Research. Target Scan, http://www.targetscan.org. Accessed April 1, 2008.
-
Target Scan
-
-
-
23
-
-
84888503505
-
-
New York University Center for Comparative Functional Genomics, Max Delbrück Center for Molecular Medicine, Accessed April 1, 2008
-
New York University Center for Comparative Functional Genomics, Max Delbrück Center for Molecular Medicine. PicTar. http://pictar.bio.nyu.edu/. Accessed April 1, 2008.
-
PicTar
-
-
-
24
-
-
33947224690
-
Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression
-
Linsley PS, Schelter J, Burchard J, et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol. 2007;27:2240-2252.
-
(2007)
Mol Cell Biol
, vol.27
, pp. 2240-2252
-
-
Linsley, P.S.1
Schelter, J.2
Burchard, J.3
-
26
-
-
21144446267
-
Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome
-
Rubio-Moscardo F, Climent J, Siebert R, et al. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood. 2005;105:4445-4454.
-
(2005)
Blood
, vol.105
, pp. 4445-4454
-
-
Rubio-Moscardo, F.1
Climent, J.2
Siebert, R.3
-
27
-
-
13544260503
-
Novel chromsomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization
-
Schraders M, Pfundt R, Straatman MP, etal. Novel chromsomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. Blood. 2005; 105:1686-1693.
-
(2005)
Blood
, vol.105
, pp. 1686-1693
-
-
Schraders, M.1
Pfundt, R.2
Straatman, M.P.3
-
28
-
-
33744832429
-
Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines
-
Camps J, Salaverria I, Garcia M, et al. Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines. Leuk Res. 2006;30:923-934.
-
(2006)
Leuk Res
, vol.30
, pp. 923-934
-
-
Camps, J.1
Salaverria, I.2
Garcia, M.3
-
29
-
-
34250805982
-
MicroRNAtarget-ing specificity in mammals: Determinants beyond seed pairing
-
Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNAtarget-ing specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27: 91-105.
-
(2007)
Mol Cell
, vol.27
, pp. 91-105
-
-
Grimson, A.1
Farh, K.K.2
Johnston, W.K.3
Garrett-Engele, P.4
Lim, L.P.5
Bartel, D.P.6
-
30
-
-
0346727524
-
MicroRNAs modulate hematopoietic lineage differentiation
-
Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83-86.
-
(2004)
Science
, vol.303
, pp. 83-86
-
-
Chen, C.Z.1
Li, L.2
Lodish, H.F.3
Bartel, D.P.4
-
31
-
-
33645278944
-
Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression
-
Grillo M, Bott MJ, Khandke N, et al. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression. Breast Cancer Res Treat. 2006;95:185-194.
-
(2006)
Breast Cancer Res Treat
, vol.95
, pp. 185-194
-
-
Grillo, M.1
Bott, M.J.2
Khandke, N.3
-
32
-
-
25144470125
-
-
Oridate N, Kim HJ, Xu X, Lotan R. Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting elF4E or cyclin D1 alone or combined with cisplatin. Cancer Biol Ther. 2005;4:318-323.32. Yasui M, Yamamoto H. Ngan CY. et al. Antisense to cyclin D1 inhibits vascular endothelial growth
-
Oridate N, Kim HJ, Xu X, Lotan R. Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting elF4E or cyclin D1 alone or combined with cisplatin. Cancer Biol Ther. 2005;4:318-323.32. Yasui M, Yamamoto H. Ngan CY. et al. Antisense to cyclin D1 inhibits vascular endothelial growth
-
-
-
-
33
-
-
33748029795
-
-
factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization. Clin Cancer Res. 2006;12:4720-4729.
-
factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization. Clin Cancer Res. 2006;12:4720-4729.
-
-
-
-
34
-
-
33846516354
-
Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma
-
Haritunians T, Mori A, O'Kelly J, Luong QT, Giles FJ, Koeffler HP. Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma. Leukemia. 2007:21:333-339.
-
(2007)
Leukemia
, vol.21
, pp. 333-339
-
-
Haritunians, T.1
Mori, A.2
O'Kelly, J.3
Luong, Q.T.4
Giles, F.J.5
Koeffler, H.P.6
-
35
-
-
34948830177
-
Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells
-
Kawamata N, Chen J, Koeffler HP. Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells. Blood. 2007;110:2667-2673.
-
(2007)
Blood
, vol.110
, pp. 2667-2673
-
-
Kawamata, N.1
Chen, J.2
Koeffler, H.P.3
-
36
-
-
33644836549
-
Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies
-
O'Connor OA, Heaney ML, Schwartz L, et al. Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies. J Clin Oncol. 2006;24: 166-173.
-
(2006)
J Clin Oncol
, vol.24
, pp. 166-173
-
-
O'Connor, O.A.1
Heaney, M.L.2
Schwartz, L.3
-
37
-
-
33750625445
-
Multicenter phase 11 study of bortezomib in patients with relapsed or refractory mantle cell lymphoma
-
Fisher RI, Bernstein SH, Kahl BS, et al. Multicenter phase 11 study of bortezomib in patients with relapsed or refractory mantle cell lymphoma. J Clin Oncol. 2006;24:4867-4874.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4867-4874
-
-
Fisher, R.I.1
Bernstein, S.H.2
Kahl, B.S.3
-
38
-
-
34250199957
-
New directions in the treatment of mantle cell lymphoma: An overview
-
Goy A. New directions in the treatment of mantle cell lymphoma: an overview. Clin Lymphoma Myeloma. 2006;7(suppl 1):S24-S32.
-
(2006)
Clin Lymphoma Myeloma
, vol.7
, Issue.SUPPL. 1
-
-
Goy, A.1
|